During the past decade, Hospital de Barbastro conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Barbastro" #1 sponsor was "Spanish Breast Cancer Research Group" with 6 trials, followed by "Grupo Espanol Multidisciplinario del Cancer Digestivo" with 1 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 1 trials sponsored, "Hospital Miguel Servet" with 1 trials sponsored and "Hospital Universitari de Bellvitge" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Barbastro" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Clinica Quiron de Zaragoza" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Barbastro" are "Breast Cancer" (6 trials), "Colorectal Cancer" (2 trials), "Breast Carcinoma Metastatic to the Bone" (1 trials), "Covid19" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "Hospital de Barbastro" in a lesser frequency.

Most popular intervention types in "Hospital de Barbastro" are "Drug" (10 trials), "Other" (4 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Cyclophosphamide" (2 trials), "Epirubicin" (2 trials), "Fulvestrant" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Barbastro" are 7 trials for "Female" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Barbastro". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital de Barbastro, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Barbastro, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".